These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
191 related articles for article (PubMed ID: 25139337)
21. Expression of interleukin-2 receptor alpha and CD45RO antigen on T lymphocytes cultured with rubella virus antigen, compared with humoral immunity in rubella vaccinees. Toyoda M; Ihara T; Nakano T; Ito M; Kamiya H Vaccine; 1999 Apr; 17(15-16):2051-8. PubMed ID: 10217606 [TBL] [Abstract][Full Text] [Related]
25. Polymorphisms in HLA-DPB1 are associated with differences in rubella virus-specific humoral immunity after vaccination. Lambert ND; Haralambieva IH; Kennedy RB; Ovsyannikova IG; Pankratz VS; Poland GA J Infect Dis; 2015 Mar; 211(6):898-905. PubMed ID: 25293367 [TBL] [Abstract][Full Text] [Related]
26. Measles and rubella antibody response after measles-mumps-rubella vaccination in children with afebrile upper respiratory tract infection. Ratnam S; West R; Gadag V J Pediatr; 1995 Sep; 127(3):432-4. PubMed ID: 7658276 [TBL] [Abstract][Full Text] [Related]
27. Genome-wide SNP associations with rubella-specific cytokine responses in measles-mumps-rubella vaccine recipients. Kennedy RB; Ovsyannikova IG; Haralambieva IH; Lambert ND; Pankratz VS; Poland GA Immunogenetics; 2014 Aug; 66(7-8):493-9. PubMed ID: 24811271 [TBL] [Abstract][Full Text] [Related]
28. Serologic response to measles-mumps-rubella vaccine among children with upper respiratory tract infection. Cilla G; Peña B; Marimón JM; Pérez-Trallero E Vaccine; 1996 Apr; 14(6):492-4. PubMed ID: 8782345 [TBL] [Abstract][Full Text] [Related]
29. Development and durability of measles antigen-specific lymphoproliferative response after MMR vaccination. Bautista-López N; Ward BJ; Mills E; McCormick D; Martel N; Ratnam S Vaccine; 2000 Jan; 18(14):1393-401. PubMed ID: 10618537 [TBL] [Abstract][Full Text] [Related]
30. Associations between single nucleotide polymorphisms in cellular viral receptors and attachment factor-related genes and humoral immunity to rubella vaccination. Haralambieva IH; Lambert ND; Ovsyannikova IG; Kennedy RB; Larrabee BR; Pankratz VS; Poland GA PLoS One; 2014; 9(6):e99997. PubMed ID: 24945853 [TBL] [Abstract][Full Text] [Related]
31. Associations between polymorphisms in the antiviral TRIM genes and measles vaccine immunity. Ovsyannikova IG; Haralambieva IH; Vierkant RA; O'Byrne MM; Poland GA Hum Immunol; 2013 Jun; 74(6):768-74. PubMed ID: 23416095 [TBL] [Abstract][Full Text] [Related]
32. A large population-based association study between HLA and KIR genotypes and measles vaccine antibody responses. Ovsyannikova IG; Schaid DJ; Larrabee BR; Haralambieva IH; Kennedy RB; Poland GA PLoS One; 2017; 12(2):e0171261. PubMed ID: 28158231 [TBL] [Abstract][Full Text] [Related]
33. [Immune status against measles and rubella among 4 Chilean groups of different ages]. Valenzuela MT; Vega J; Leal I; Vicente M; Young V; Vera L; Fasce R; Ramírez E Rev Med Chil; 1999 Mar; 127(3):359-65. PubMed ID: 10436723 [TBL] [Abstract][Full Text] [Related]
34. TLR3 and RIG-I gene variants: associations with functional effects on receptor expression and responses to measles virus and vaccine in vaccinated infants. Clifford HD; Yerkovich ST; Khoo SK; Zhang G; Upham J; Le Souëf PN; Richmond P; Hayden CM Hum Immunol; 2012 Jun; 73(6):677-85. PubMed ID: 22504413 [TBL] [Abstract][Full Text] [Related]
35. Immunity against measles and rubella in Massachusetts schoolchildren. Orenstein WA; Herrmann K; Albrecht P; Bernier R; Holmgreen P; Bart KJ; Hinman AR Dev Biol Stand; 1986; 65():75-83. PubMed ID: 3556779 [TBL] [Abstract][Full Text] [Related]
36. Rubella virus-specific humoral immune responses and their interrelationships before and after a third dose of measles-mumps-rubella vaccine in women of childbearing age. Haralambieva IH; Ovsyannikova IG; Kennedy RB; Goergen KM; Grill DE; Chen MH; Hao L; Icenogle J; Poland GA Vaccine; 2020 Jan; 38(5):1249-1257. PubMed ID: 31732325 [TBL] [Abstract][Full Text] [Related]
37. Evaluation of a two-dose measles, mumps, and rubella vaccination schedule in a cohort of college athletes. Coté TR; Sivertson D; Horan JM; Lindegren ML; Dwyer DM Public Health Rep; 1993; 108(4):431-5. PubMed ID: 8341775 [TBL] [Abstract][Full Text] [Related]
38. Seroconversion rates to combined measles-mumps-rubella-varicella vaccine of children with upper respiratory tract infection. Dennehy PH; Saracen CL; Peter G Pediatrics; 1994 Oct; 94(4 Pt 1):514-6. PubMed ID: 7936862 [TBL] [Abstract][Full Text] [Related]
39. Evaluation of a combined measles-mumps-rubella-chickenpox vaccine. Just M; Berger R; Just V Dev Biol Stand; 1986; 65():85-8. PubMed ID: 3030863 [TBL] [Abstract][Full Text] [Related]
40. [Preliminary study on nasal spray of interferon alpha-2b used for prevention of rubella and measles virus infections]. Zhao J; Zhu FC; Shu YL; Zhou R; Liu LQ; Zhang LL; Shi ZY; Tang Z; Lin LZ; Yu ZA; Zhang LP; Zhang B; Hou YD Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2005 Sep; 19(3):220-2. PubMed ID: 16261201 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]